Navigation Links
Director of UT Southwestern center honored with first international neurology medal
Date:9/28/2009

that accumulates in the brains of people with Alzheimer's. He recently received a patent for this approach.

Among his many publications is The Molecular and Genetic Basis of Neurological and Psychiatric Disease, the leading textbook in the field, which is now in its fourth edition.

Dr. Rosenberg attended Tufts University and received his bachelor's degree in biochemistry and medical degree with distinction from Northwestern University. He joined the UT Southwestern faculty in 1973, served as chairman of neurology until 1991 and became director of the Alzheimer's Disease Center in 1988.

The center, one of 32 funded by the National Institutes of Health, contains five core groups that conduct clinical research, study the neuropathology of Alzheimer's, provide education and outreach to the community, support data management and provide administrative functions.

Dr. Rosenberg served as president of the American Academy of Neurology from 1991 to 1993. He is editor-in-chief of Archives of Neurology and a member of the editorial board of the Journal of the American Medical Association.


'/>"/>

Contact: Aline McKenzie
aline.mckenzie@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. CONRAD executive director to give Guttmacher lecture at Reproductive Health 2009
2. George Fox University Hosts Oregon Center for Nursing Director Oct. 15
3. Caraco Pharmaceutical Laboratories, Ltd. Announces Resignation of Georges Ugeux from Board of Directors
4. R. Kerry Clark and Robert J. Palmisano Join Bausch & Lomb Board of Directors
5. HealthFitness President Gregg O. Lehman Named to DMAA Board of Directors
6. YourCity.MD's city health directory portals Put Local TV Broadcasters in a Position to Dominate Local Healthcare Revenues, from the Web!
7. Public Option Still Viable As House Set to Pass It -- Not Fading, Says Robert Weiner, Former House Aging Committee Director
8. Jemicy Head of School, Ben Shifrin, Named to Board of Directors of the International Dyslexia Association
9. IH Systems RIVA Top Pick for Directors of Pharmacy
10. New Nominee for WHO Regional Director for Europe
11. UPS Chief Named to U.S. Fund for UNICEFs Board of Directors

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Director of UT Southwestern center honored with first international neurology medal
Director of UT Southwestern center honored with first international neurology medal
(Date:11/23/2009)...itationforFivePopulationHealthPrograms ,, LOVE...tionHealthImpactInstitute(PHII),anon-profit501(c)(...ofDirectorshasapprovedtheHealthcareTransparencyAcc...velopment.Nurtur(TM),alife,health,andwellnesscompa...ivetheH-TAPaccreditationsealforfiveofitsprograms. ...
(Date:11/23/2009).../PRNewswire/--ChristineHoehnehasjoined LocktonBene...brokerage.HoehnewillserveasanAccountExecutiveinLoc...ton,s Minneapolis office. ,, (Logo: http://www...., "WearethrilledtohaveChristinejoinourteam,"said...rvices."Shebroadensourabilitytoassistourmultinatio...
(Date:11/23/2009)...splants need longer-term support than most friends...se, according to a study of 160 patients published... Advanced Nursing . , Researchers surveyed 5...ear, together with 105 who had had surgery in the ...nt Center in Tennessee, USA. They wanted to see if...
(Date:11/23/2009)...1, has understandably captured the attention of pu...owever, an analysis from Children,s Hospital Bosto...ent (ED) during several recent flu seasons, shows ...SV) -- takes a substantially greater disease toll ...lthough the data come from the pre-H1N1 influenza ...
(Date:11/23/2009)...te Helps Organizations Meet HIPAA Compliance Requi...nd Eligibility, , (PRWEB)...leading provider of high-performance data integrat...y the launch of new products within its healthcare... other healthcare organizations meet industry stan...
Breaking Medicine News(10 mins):Health News:Population Health Impact Institute Launches Healthcare Transparency Accreditation Program(TM) 2Health News:Population Health Impact Institute Launches Healthcare Transparency Accreditation Program(TM) 3Health News:Lockton Benefit Group Expands International Benefit Team 2Health News:Drug side effects a key factor in reduced quality of life for kidney transplant patients 2Health News:Drug side effects a key factor in reduced quality of life for kidney transplant patients 3Health News:Amid the flu epidemic, don't forget RSV in young children 2Health News:Amid the flu epidemic, don't forget RSV in young children 3Health News:BridgeGate Launches New Healthcare Integration and Interoperability Products 2Health News:BridgeGate Launches New Healthcare Integration and Interoperability Products 3Health News:BridgeGate Launches New Healthcare Integration and Interoperability Products 4
...igher quality diets also associated with higher in... (HealthDay News) -- People with higher levels of ...but pay more for selecting foods that are less ene...abetes, cardiovascular disease and some forms of c...
... Data Presented at American Heart Association ATVB...e Volume and Fewer New Plaque Lesions in Treated P...VIA Pharmaceuticals, Inc. (Nasdaq: VIAP ) today ...d tomography (MDCT) scans before and after six mon...
... COSTA MESA, Calif., May 1 Oxygen Biotherapeutics...that the company has filed a Cosmetic Product Ingr...(TM) Gel, its new Oxycyte(R)-based cosmetic produc...ep closer to bringing our first product to market,...
... - Therapy is medically-necessary for thousands of...ue to cystic fibrosis or other conditions - , , ... today announced that the U.S. Food and Drug Admin...ibrosis (CF) or other conditions. CREON(R) is the ...
... Revenue Up 28%, EPS Up 77% Over Prior Year , , N...ced financial results for its first quarter ended ...9, revenue increased 28.2% to $49.9 million, compa...come of $3.2 million or $0.12 per fully diluted sh...
... Full-Year 2009 Guidance Range Increased to $2.70 ..., May 1, 2009 AMERIGROUP Corporation (NYSE: AGP...st quarter of 2009 increased 9.7% to $36.9 million...hlights include: , , , , Membership in...
Other Medicine News:Health News:More Educated Choose Healthier Foods, But Pay More 2Health News:VIA Pharmaceuticals Announces Positive Phase 2 Results of VIA-2291 in Cardiovascular Patients Using Serial MDCT Imaging of Coronary Plaque 2Health News:VIA Pharmaceuticals Announces Positive Phase 2 Results of VIA-2291 in Cardiovascular Patients Using Serial MDCT Imaging of Coronary Plaque 3Health News:VIA Pharmaceuticals Announces Positive Phase 2 Results of VIA-2291 in Cardiovascular Patients Using Serial MDCT Imaging of Coronary Plaque 4Health News:VIA Pharmaceuticals Announces Positive Phase 2 Results of VIA-2291 in Cardiovascular Patients Using Serial MDCT Imaging of Coronary Plaque 5Health News:Oxygen Biotherapeutics, Inc. Files Cosmetic Product Ingredient Statement for new Oxycyte-based Cosmetic Gel 2Health News:Oxygen Biotherapeutics, Inc. Files Cosmetic Product Ingredient Statement for new Oxycyte-based Cosmetic Gel 3Health News:Video: CREON(R) (Pancrelipase) Delayed-Release Capsules First and Only Pancreatic Enzyme Product to Receive FDA Approval Under New Guidelines 2Health News:Video: CREON(R) (Pancrelipase) Delayed-Release Capsules First and Only Pancreatic Enzyme Product to Receive FDA Approval Under New Guidelines 3Health News:Video: CREON(R) (Pancrelipase) Delayed-Release Capsules First and Only Pancreatic Enzyme Product to Receive FDA Approval Under New Guidelines 4Health News:Video: CREON(R) (Pancrelipase) Delayed-Release Capsules First and Only Pancreatic Enzyme Product to Receive FDA Approval Under New Guidelines 5Health News:HMS Holdings Corp. Announces First Quarter 2009 Financial Results 2Health News:HMS Holdings Corp. Announces First Quarter 2009 Financial Results 3Health News:HMS Holdings Corp. Announces First Quarter 2009 Financial Results 4Health News:HMS Holdings Corp. Announces First Quarter 2009 Financial Results 5Health News:HMS Holdings Corp. Announces First Quarter 2009 Financial Results 6Health News:HMS Holdings Corp. Announces First Quarter 2009 Financial Results 7Health News:HMS Holdings Corp. Announces First Quarter 2009 Financial Results 8Health News:HMS Holdings Corp. Announces First Quarter 2009 Financial Results 9Health News:HMS Holdings Corp. Announces First Quarter 2009 Financial Results 10Health News:HMS Holdings Corp. Announces First Quarter 2009 Financial Results 11Health News:AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share 2Health News:AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share 3Health News:AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share 4Health News:AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share 5Health News:AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share 6Health News:AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share 7Health News:AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share 8Health News:AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share 9Health News:AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share 10Health News:AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share 11Health News:AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share 12Health News:AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share 13Health News:AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share 14Health News:AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share 15
(Date:11/23/2009)...ov.23/PRNewswire-FirstCall/--WoundManagementTechno...providerofspecialtymedicalproducts,announcedthatit...prehensivemanagementbusinessupdatetoillustratethed...9salesincreased33.5%to$102,926vs.Q32008salesof$77,...dto$3,327,892vs.Q32008shareholderequityof$(321,257...
(Date:11/23/2009)...v.23/PRNewswire-FirstCall/--Pharmasset,Inc.(Nasdaq...edbyitspartnerRoche(SWX:ROG.VX;RO.S,OTCQX:RHHBY),w...intheongoingphase2btrialofRG7128,afirst-in-classnu...chronichepatitisCvirus(HCV)infection.Thedecisionwa...nitoringCommittee(DMC)ofallavailablesafetydatafrom...
(Date:11/23/2009)...ZER,Pa.,Nov.23/PRNewswire-FirstCall/--CeptionThera...y,andCephalon,Inc.(Nasdaq: CEPH )todayannouncedres...eslizumab)asatreatmentforpediatriceosinophilicesop...entintheco-primaryendpointsofchangesinesophagealeo...aindicatedthatpatientstreatedwithCINQUILshowedasta...
Breaking Medicine Technology:Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 2Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 3Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 4Wound Management Technologies (OTCBB: WNDM) Reports Revenue Increase of 33.5%; Posts Evidence-Based Studies for CellerateRx; and Business Update 5Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 2Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 3Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 4Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis 2Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis 3Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis 4Shamir Optical Industry Ltd Reports Second Quarter 2009 Results 54429 1Shamir Optical Industry Ltd Reports Second Quarter 2009 Results 54429 2Shamir Optical Industry Ltd Reports Second Quarter 2009 Results 54429 3Shamir Optical Industry Ltd Reports Second Quarter 2009 Results 54429 4Shamir Optical Industry Ltd Reports Second Quarter 2009 Results 54429 5Shamir Optical Industry Ltd Reports Second Quarter 2009 Results 54429 6Shamir Optical Industry Ltd Reports Second Quarter 2009 Results 54429 7Shamir Optical Industry Ltd Reports Second Quarter 2009 Results 54429 8Shamir Optical Industry Ltd Reports Second Quarter 2009 Results 54429 9Shamir Optical Industry Ltd Reports Second Quarter 2009 Results 54429 10Impact of cannabis on bones changes with age study finds 54427 1Interventional radiology treatment for uterine fibroids 3A Safe nonsurgical option 54424 1Interventional radiology treatment for uterine fibroids 3A Safe nonsurgical option 54424 2Interventional radiology treatment for uterine fibroids 3A Safe nonsurgical option 54424 3
...ansdel,Pharmaceuticals, Inc. (OTC Bulletin Board: ...and Drug Administration,s ("FDA") review of its Ph...e 3 clinical program for its,novel topical cream b...),Ketotransdel(TM). Transdel Pharmaceuticals is a ...lopment and commercialization of non-invasive,topi...
...ular Structures Needed for siRNA ...8 Silence Therapeutics plc,(AIM:SLN) Europe,s lea...ments on two recent journal articles: Nature(1) "S...ssion by siRNA via TLR3" Mark E.,Kleinman, et. al....,siRNA/Liposome Complexes in Mice is Sequence-Inde...
Other Medicine Technology:Transdel Pharmaceuticals Advances Lead Topical Pain Drug into Phase 3 Program 2Transdel Pharmaceuticals Advances Lead Topical Pain Drug into Phase 3 Program 3Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach 2Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach 3Recent siRNA Research Publications Support Silence Therapeutics Combined Development Approach 4
SMZ-660
SMZ-645
SMZ-1500
Achroplan Wasser objectives
Medicine Products: